Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 11.0% | 12.7% | 11.4% | 12.9% | 14.4% | 14.7% | 15.2% | 15.3% | 15.2% | 13.1% | 13.7% | 13.5% | 14.4% | 14.3% | 18.8% | 11.0% | 11.2% | 9.3% | 6.1% | 4.8% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 5.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Equity (ROE) for Fresenius Medical Care AG & Co. KGaA have been 6.5% over the past three years, and 8.3% over the past five years.
As of today, Fresenius Medical Care AG & Co. KGaA's Return on Equity (ROE) is 5.1%, which is lower than industry median of 6.9%. It indicates that Fresenius Medical Care AG & Co. KGaA's Return on Equity (ROE) is Bad.